SAN MATEO, Calif.
- Jan. 10, 2014
-- Persistence Market Research, a global healthcare research firm announced their plans to undertake the study of the Artificial Pancreas Market. Artificial Pancreas are ambulatory or portable insulin pumps that continuously monitor an individual’s insulin levels and automatically inject appropriate levels of insulin into the body. Persistence Market Research predicts the Artificial Pancreas will be the top diabetes care technology in the next few years and may soon replace the conventional needle injectable insulin. There are an estimated 347 million people globally affected by diabetes and require constant attention to their insulin levels.Navigate through the link below to pre-order a copy of this report today and avail a discount between 10% - 15% on the listed price of $3775.
The report estimates the market for artificial pancreas in several regions such as North America, Europe, Asia-Pacific, Latin America along with Middle-East and Africa (MEA). The report will also include several trends in growth of diabetes and impact of substitutes to artificial pancreas. The study will also understand the distribution of diabetics throughout the world by region along with the drivers and inhibitors for the growth of the market. The report will include a forecast of the market from 2014 to 2020 with base statistics from 2012 and 2013. Persistence Market Research report will also profile key players in the segment such as Medtronic, Johnson & Johnson, DexCom and other innovative players such as Pancreum, AccuChek and Blatchford.